No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AFYA Afya Ltd
- 17.730
- -0.010-0.06%
Close Jul 19 16:00 ET
1.56BMarket Cap18.90P/E (TTM)
18.140High17.650Low111.94KVolume17.770Open17.740Pre Close2.00MTurnover5.38%Turnover Ratio23.24P/E (Static)88.06MShares22.48052wk High2.29P/B36.87MFloat Cap14.27052wk Low--Dividend TTM2.08MShs Float34.870Historical High--Div YieldTTM2.76%Amplitude8.730Historical Low17.876Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Despite Delivering Investors Losses of 25% Over the Past 3 Years, Afya (NASDAQ:AFYA) Has Been Growing Its Earnings
While it may not be enough for some shareholders, we think it is good to see the Afya Limited (NASDAQ:AFYA) share price up 16% in a single quarter. But that cannot eclipse the less-than-
As Afya (NASDAQ:AFYA) Grows 4.9% This Past Week, Investors May Now Be Noticing the Company's Three-year Earnings Growth
Afya Limited Announces Medical Seats Increase in UNIMA Alagoas
Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision
Afya Closes $116.7 Million Acquisition of Unidom Participacoes
Afya (AFYA) said Monday it has closed its 660 million Brazilian reais ($116.7 million) acquisition of Unidom Participacoes. The acquisition adds 300 operational medical school seats in the Brazilian c
Express News | Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz
Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 43%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Afya fair value estimate is US$30.72 Afya is estimated to be 43% undervalued based on current share price of US$17.65 Our fair value estima
Comments
The stock is undervalued and its bright future isn't fully reflected in the current price, indicating a potential buying opportunity. However, consider other factors like capital structure before investing.
Is It Too Late To Consider Buying Afya Limited (NASDAQ:AFYA)? 2
Afya exhibits robust financials, boasting a good ROE and extraordinary net income growth exceeding industry norms. The company's effective reinvestment of profits might contribute to the high earnings growth. Analysts predict a future acceleration in Afya's earnings.
Shareholders may consider selling Afya stocks given the current valuation, expecting to buy back at lower prices. Despite Afya's positive outlook, the hefty price tag indicates that its future growth may already be priced in.
Upgrades
• $Afya Ltd(AFYA.US$: Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $18)
• $Appfolio(APPF.US$: KeyBanc Upgrades to Overweight from Sector Weight - PT $143
• $C.H. Robinson Worldwide(CHRW.US$: JPMorgan Upgrades to Overweight from Neutral - PT $117 (from $91)
• $Coupang(CPNG.US$: Goldman Sachs Upgrades to Conviction Buy from Buy - PT $37
• $Gatos Silver(GATO.US$: RBC Capital Upgrades to Sector Perform from Underperform - PT $4
• $ITT Inc(ITT.US$: UBS Upgr...
• $Afya Ltd(AFYA.US$: Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $18)
• $Appfolio(APPF.US$: KeyBanc Upgrades to Overweight from Sector Weight - PT $143
• $C.H. Robinson Worldwide(CHRW.US$: JPMorgan Upgrades to Overweight from Neutral - PT $117 (from $91)
• $Coupang(CPNG.US$: Goldman Sachs Upgrades to Conviction Buy from Buy - PT $37
• $Gatos Silver(GATO.US$: RBC Capital Upgrades to Sector Perform from Underperform - PT $4
• $ITT Inc(ITT.US$: UBS Upgr...
16
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg